| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-05-27 |
4 |
OE |
$11.92 |
$834,400 |
D/D |
70,000 |
1,102,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-06-20 |
4 |
OE |
$11.92 |
$1,076,138 |
D/D |
90,280 |
1,122,611 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-08-23 |
4 |
AS |
$15.55 |
$144,068 |
D/D |
(9,167) |
217,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-10-22 |
4 |
AS |
$16.85 |
$288,687 |
D/D |
(17,000) |
249,312 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-09-24 |
4 |
AS |
$17.45 |
$161,139 |
D/D |
(9,167) |
237,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-12 |
4 |
OE |
$17.65 |
$1,420,084 |
D/D |
80,458 |
1,107,644 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-13 |
4 |
OE |
$17.65 |
$433,166 |
D/D |
24,542 |
1,051,728 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-14 |
4 |
OE |
$17.65 |
$617,750 |
D/D |
35,000 |
1,062,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-15 |
4 |
OE |
$17.65 |
$617,750 |
D/D |
35,000 |
1,062,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-16 |
4 |
OE |
$17.65 |
$565,630 |
D/D |
32,047 |
1,053,321 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-04 |
4 |
OE |
$17.98 |
$1,540,311 |
D/D |
85,668 |
1,106,942 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-05 |
4 |
OE |
$17.98 |
$1,634,724 |
D/D |
90,919 |
1,112,193 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-08 |
4 |
OE |
$17.98 |
$381,428 |
D/D |
21,214 |
1,042,488 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-10 |
4 |
A |
$17.98 |
$219,338 |
D/D |
12,199 |
1,033,473 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-05 |
4 |
OE |
$17.98 |
$1,019,844 |
D/D |
56,721 |
1,000,397 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-08 |
4 |
OE |
$17.98 |
$1,307,156 |
D/D |
59,934 |
1,003,610 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-08 |
4 |
AS |
$19.94 |
$155,552 |
D/D |
(7,801) |
255,312 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-05 |
4 |
AS |
$20.00 |
$3,980 |
D/D |
(199) |
249,660 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2003-10-02 |
4 |
AS |
$20.01 |
$80,040 |
D/D |
(4,000) |
215,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2003-12-02 |
4 |
AS |
$20.20 |
$80,800 |
D/D |
(4,000) |
214,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-22 |
4 |
AS |
$20.20 |
$507,189 |
D/D |
(25,000) |
274,062 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-02-09 |
4 |
AS |
$20.58 |
$82,300 |
D/D |
(4,000) |
210,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
officerTitle |
• • – |
2006-01-09 |
4 |
A |
$20.72 |
$233,100 |
D/D |
11,250 |
311,511 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-05-10 |
4 |
AS |
$21.01 |
$84,040 |
D/D |
(4,000) |
200,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-01-28 |
4 |
A |
$22.90 |
$24,045 |
D/D |
1,050 |
920,138 |
0 |
- |
|
283 Records found
|
|
Page 4 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
